Steven Holman
Gerontology · Caro, MINPI 1851718399
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2023 at $600 and has fallen 92.3% since, to $46 in 2025.
Across 88 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$413
- Amgen$114
- Bayer$106
- Boehringer Ingelheim$97
- Philips North America LLC$95
- Novo Nordisk$92
- plus $789 from 22 others
What the payments were for
- Food & beverage$1,707100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $413 |
| Amgen | 6 | $114 |
| Bayer | 5 | $106 |
| Boehringer Ingelheim | 1 | $97 |
| Philips North America LLC | 6 | $95 |
| Novo Nordisk | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
| Mylan Specialty L.p. | 4 | $64 |
| CMP Pharma, Inc. | 1 | $63 |
| Nestle Healthcare Nutrition Inc. | 3 | $61 |
| Novartis | 3 | $49 |
| Merck | 3 | $44 |
| Corcept Therapeutics | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Neurocrine Biosciences, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Urovant Sciences Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$1,707 in reported general payments places this provider in the 75th percentile of 279 gerontology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 98 | $65,908 |
| JardianceEmpagliflozin | 79 | $62,621 |
| EliquisApixaban | 59 | $39,951 |
| Nurtec OdtRimegepant Sulfate | 22 | $38,364 |
| FarxigaDapagliflozin Propanediol | 48 | $31,046 |
| JanuviaSitagliptin Phosphate | 39 | $26,341 |
| EntrestoSacubitril/Valsartan | 33 | $25,062 |
| TrulicityDulaglutide | 20 | $20,945 |
| OzempicSemaglutide | 22 | $20,859 |
| XareltoRivaroxaban | 13 | $12,733 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,543 |
| BrilintaTicagrelor | 25 | $10,910 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $6,536 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 335 | $6,355 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $6,009 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $97 | $68,43690 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $19 | $59,509113 claims |
| MerckJanuvia, Janumet | $44 | $32,87851 claims |
| NovartisEntresto | $49 | $25,06233 claims |
| Lilly USA, LLCTrulicity | $28 | $20,94520 claims |
| Novo NordiskOzempic | $92 | $20,85922 claims |
| Sanofi-aventis U.S. LLCLantus | $13 | $66811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 279 gerontology providers in Michigan.
Other gerontology in Caro
- Alicia McLarenCaro$3K
- Gwendolyn WrightGrand Blanc$47K
- Matthew AmanRochester Hills$21K
- Sarah ArnkoffWest Bloomfield$18K
- Deborah GriffinPetoskey$11K
- Angela EmbreeGrand Rapids$10K
- Bethany DalessandroWyandotte$10K
- Gabrielle NadeauJackson$10K
- Cynthera McNeillWest Bloomfield$9K
- Samantha BurgessGrand Rapids$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.